Papers: 10.1371/journal.pone.0207872

https://doi.org/10.1371/journal.pone.0207872

Novel high–throughput myofibroblast assays identify agonists with therapeutic potential in pulmonary fibrosis that act via EP2 and EP4 receptors

Cited by: 20
Author(s): Patrick Sieber, Anny Schäfer, Raphael Lieberherr, François Le Goff, Manuel Stritt, Richard W. D. Welford, John Gatfield, Oliver Peter, Oliver Nayler, Urs Lüthi
Published: over 6 years ago

Software Mentions 1